LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Fri, 19 Oct 2001 07:16:32 EDT
Content-Type:
text/plain
Parts/Attachments:
text/plain (28 lines)
Someone pointed out that Cipro is:

> .  It is classified as "usually
> > compatible with breastfeeding" in the newest AAP Policy Statement, "The
> > transfer of drugs and other chemicals into human milk"[Pediatrics 108:3,
> p
> > 799].  Thomas Hale places Cipro into lactation risk category L4, citing a
> > possible risk of serious joint and GI system side effects.  Category L4
> > calls for a risk-benefit analysis before the decision is made to use the
> > drug in a breastfeeding mother. [Medications and Mothers' Milk, 2000
> > edition, pp 16, 147-8]
>
There was a notice on the news about Cipro causing arthroscopic problems in
dogs, but said it had never been demonstrated in humans, and that at the
doses babies receive, would not be a problem,  My first and immediate
reaction to that was that the amount that babies would receive thru the
breastmilk would be even less of a problem than receiving it first hand.

Jan Barger, RN, MA, IBCLC -- Wheaton IL
Lactation Education Consultants
www.lactationeducationconsultants.com

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2